theratech.com - Nilai bisnis marang pendapatan THTX

Logo perusahaan publik Theratechnologies, Inc. (THTX)

Risks of a narrow distribution channel and expensive borrowing limit the growth of Theratechnologies Inc. (THTX), as confirmed by the EV/Sales multiple history. Meanwhile, the brand is valued for its HIV therapy efficacy, and its potential is expanding through oncology developments. The mark serves as a current indicator demonstrating real demand for the asset, accounting for the debt load and cost inflation.

Theratechnologies, Inc (THTX): Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Theratechnologies (THTX)

- rega saham lan target rega konsensus:
Pambiji fundamental perusahaan:THTX, Theratechnologies Inc.
Produk seri theratech.com

Fundamental asset screening begins with an analysis of a business's market value relative to its operating income. The current EV/Revenue ratio reflects the relationship between the total enterprise value and sales volume, excluding the impact of the debt structure. An increase in this metric signals overvaluation, while a decrease suggests potential undervaluation. For Theratechnologies Inc. (THTX), stable demand for HIV drugs smooths the volatility of this indicator, although oncology development costs limit profitability growth.

Analisis pesaing Theratechnologies Inc.

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD